Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Steven J. Mento currently holds 10,000 shares of Conatus Pharmaceuticals Inc (CNAT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Steven J. Mento has been a net seller of CNAT stock. They have purchased $151.8K and sold $1.7M worth of shares.
Steven J. Mento's most recent insider trade was on Jan 4, 2024, when they sold 10,000 shares at $0.00 per share.
Steven J. Mento serves as Executive at Conatus Pharmaceuticals Inc (CNAT). They have executed 45 insider transactions totaling $1.9M over their tenure at the company.
Steven J. Mento holds the position of Executive at Conatus Pharmaceuticals Inc, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 19 years and currently hold a stake valued at $0.
Steven J. Mento has shown a selling trading pattern, with $151.8K in total purchases and $1.7M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Steven J. Mento was on Feb 1, 2018, when they sold $237.2K worth of SGMO shares. This transaction involved 11,520 shares at $20.59 per share.
Steven J. Mento currently owns 10,000 shares of Conatus Pharmaceuticals Inc (CNAT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Steven J. Mento's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Steven J. Mento has 45 Form 4 filings on record as an insider at Conatus Pharmaceuticals Inc.
Set alerts for Steven J. Mento and 40,000+ other insiders.